Education
About Us
Working with TipRanks
Follow Us
David Joshua Bartch Insider Profile
4 Followers
David Joshua Bartch, Chief Executive Officer at Mydecine Innovations Group, holds 1.48M shares in Mydecine Innovations Group (Ticker: TSE:NVRS). Most recently, David Joshua Bartch ― shares of Mydecine Innovations Group on ― for an estimated value of ―.
David Joshua Bartch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Joshua Bartch's holdings
Insider Roles
Chief Executive Officer
Roles that David Joshua Bartch holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Joshua Bartch
David Joshua Bartch's Trading History
List of latest transactions for each holding click on a transaction to see David Joshua Bartch's performance on stock
You May Also Like
David Joshua Bartch insider profile FAQ
What is the percentage of profitable transactions made by David Joshua Bartch?
The percentage of profitable transactions made by David Joshua Bartch is ―.
What is the average return per transaction made by David Joshua Bartch?
The average return per transaction made by David Joshua Bartch is ―.
What stocks does David Joshua Bartch hold?
David Joshua Bartch holds: TSE:NVRS stocks.
What was David Joshua Bartch’s latest transaction?
David Joshua Bartch latest transaction was an Uninformative Buy of ―.
What was David Joshua Bartch's most profitable transaction?
David Joshua Bartch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Joshua Bartch's role in Mydecine Innovations Group?
David Joshua Bartch's role in Mydecine Innovations Group is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.